Biotechs

…

Last Updated: January 18, 2023, 11:02 ISTIn December, the intranasal Covid-19 vaccine was approved by the Union Health Ministry as a booster dose for those aged 18 and above. (Twitter @PBNS_India)Nasal vaccines can be be more effective at…

Representational image. News18…

Image for representational purposes only. | Photo Credit: The Hindu Hyderabad-based Bharath Biotech said Tuesday that its nasally administered vaccine, iNCOVACC, would be available for public use from the fourth week of January and cost…

Representational image. AP…

Bharat Biotech has been asked to submit safety data alongwith the data on adverse event with due analysis, every 15 days for the first two months and after that monthly data for up to five months…

Covaxin can give protection against Omicron and other COVID variants if you take the third vaccine dose around 6 months after the first two doses, a study by ICMR and Bharat Biotech revealed. A few days back, Serum Institute of…

The World Health Organization said on Saturday (Apr 2) it has suspended supply through United Nations agencies of COVID-19 vaccine Covaxin, produced by India's Bharat Biotech, to allow the manufacturer to upgrade facilities and address…

Covaxin maker Bharat Biotech International CMD Krishna Ella, who was among 74 distinguished personalities receiving Padma awards on Monday, took born into a farming family in Tamil Nadu and set out into the world of biotechnology through…

DCGI's Subject Expert Committee (SEC) has granted 'in principle' approval to Bharat Biotech for the conduct of 'Phase III superiority study and Phase III booster dose study' for its intranasal COVID vaccine and has asked it to…